BrainScan, high sensitivity p-tau217 blood test for Alzheimer’s risk now in Australia.
Discover what is happening in your brain, 10-20 years before symptoms appear.
“Its even easier than getting a blood test to get your cholesterol checked.”
Inside the p-tau 217 brain risk insights panel.
For decades, Alzheimer’s risk was only recognised once symptoms appeared or after invasive, costly tests. That has changed. Today, simple blood tests can detect biological changes years decades before memory symptoms occur.
The brain risk insights panel measures three different blood markers:
High-sensitivity p-tau 217 (p-tau217): p-tau217 is closely aligned with amyloid pathology. It is highly predictive of Alzheimer’s insights.
Glial Fibrillary Acidic Protein (GFAP): GFAP provides insights to levels of brain inflammation and injury.
Neurofilament Light Chain(Nf-L): Nf-L levels provide insights to nerve cell damage and neurodegeneration.
The test is available to order now. You can order it directly through our collaborative partners at Optilabs.
You’ve received your BrainScan report. Now what?
You are invited to schedule a session to learn about your BrainScan risk insights p-tau217, GFAP and Nf-L report here.
$75 | 30 mins